GlaxoSmithKline/Adolor Halt Entereg Bowel Dysfunction Program Due To Cardiovascular Events
Top-line, 12-month Phase III safety data underscore CV concerns and raise new adverse event questions.
Top-line, 12-month Phase III safety data underscore CV concerns and raise new adverse event questions.